COMMUNIQUÉS West-GlobeNewswire

Keros Therapeutics Appoints Anne Prener to its Board of Directors
25/06/2026
LEXINGTON, Mass., June 25, 2026 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel [...]
NRx Pharmaceuticals Responds to Recent Public Statements Regarding Kadima Dispute
25/06/2026
WILMINGTON, Del., June 25, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx” or the “Company”) today issued the following statement in response to recent public claims made by Kadima [...]
Ligand Announces Closing of Convertible Senior Notes Offering
25/06/2026
Opportunistic capital raise with proceeds used to enhance financial flexibility A portion of the proceeds to be used to purchase call spreads and to fund concurrent share repurchase intended to offset potential dilution [...]
PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE YEAR 2026 ENDED MARCH 31, 2026
25/06/2026
MINNEAPOLIS, MN, US, June 25, 2026 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX: PETV) (OTCID: PETVW), in cooperation with its wholly-owned subsidiaries, Cosmeta Corp, PetVivo Animal Health, Inc. and PetVivo AI, [...]
Regeneron to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast
25/06/2026
TARRYTOWN, N.Y., June 25, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN ) today announced that it will report its second quarter 2026 financial and operating results on Thursday, July 30, 2026, [...]
Valneva Announces Successful Outcome of its Annual General Meeting
25/06/2026
Dr. Gerd Zettlmeissl is appointed as Chair of the Board of Directors Lyon (France), June 25, 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that shareholders approved [...]
Chiesi Group and Arbor Biotechnologies Announce ABO-101 Granted Orphan Drug Designation by European Commission for Primary Hyperoxaluria
25/06/2026
ABO-101 is an investigational gene editing therapy designed to address the underlying disease biology of PH1 by reducing hepatic oxalate production Orphan Drug Designation (ODD) highlights the need for additional [...]
Chiesi Group and Arbor Biotechnologies Announce ABO-101 Granted Orphan Drug Designation by European Commission for Primary Hyperoxaluria
25/06/2026
ABO-101 is an investigational gene editing therapy designed to address the underlying disease biology of PH1 by reducing hepatic oxalate production Orphan Drug Designation (ODD) highlights the need for additional [...]
Valneva annonce l’approbation des résolutions présentées à son Assemblée Générale
25/06/2026
Le Dr Gerd Zettlmeissl est nommé président du conseil d’administration Lyon (France), le 25 juin 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), société spécialisée dans les vaccins, a annoncé aujourd'hui que [...]
Xealth Survey Defines Digital Readiness Gaps Between Healthcare Executives and Physicians
25/06/2026
New market insights identify misaligned operational priorities in digital health and outline a framework for unification SEATTLE, June 25, 2026 (GLOBE NEWSWIRE) -- Xealth , the leader in digital health orchestration and [...]
Regenix Labs Announces Educational Guide on NAD+, Cellular Energy, and Healthy Aging
25/06/2026
New online guide explores NAD+, cellular energy production, and healthy aging research Regenix Labs logo. NEWARK, Del., June 25, 2026 (GLOBE NEWSWIRE) -- Regenix Labs LLC announces the availability of its educational [...]
Two of Canada’s top athletes named Canadian Red Cross monthly giving ambassadors
25/06/2026
Alphonso Davies and Leylah Fernandez partnering with the Canadian Red Cross OTTAWA, June 25, 2026 (GLOBE NEWSWIRE) -- The Canadian Red Cross is pleased to announce Canadian men’s national soccer team captain Alphonso [...]
Deux athlètes d’élite du Canada deviennent ambassadeurs du programme de dons mensuels de la Croix-Rouge canadienne
25/06/2026
Alphonso Davies et Leylah Fernandez s’associent à la Croix-Rouge canadienne OTTAWA, 25 juin 2026 (GLOBE NEWSWIRE) -- La Croix-Rouge canadienne est heureuse d’annoncer que la grande joueuse de tennis canadienne Leylah [...]
First Stop Health Enhances Healthy Weight Program amid Growing GLP-1 Employee Demand and Employer Costs
25/06/2026
Program provides employers simple, clinically governed GLP-1 management options regardless of plan coverage CHICAGO, June 25, 2026 (GLOBE NEWSWIRE) -- First Stop Health, the connected, whole-person virtual care platform [...]
Commure Named “Overall NLP Company of the Year” in 2026 AI Breakthrough Awards
25/06/2026
Recognition highlights Commure’s AI-native platform transforming healthcare operations at scale MOUNTAIN VIEW, Calif., June 25, 2026 (GLOBE NEWSWIRE) -- Commure , a leading healthcare technology company, today announced [...]
Atea Pharmaceuticals Completes Patient Enrollment in Phase 3 C-FORWARD Trial Evaluating Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus
25/06/2026
Topline Phase 3 Results from C-FORWARD Expected Around Year-End 2026 More Than 880 HCV Treatment-Naïve Patients Enrolled Across 17 Countries Outside North America C-FORWARD and C-BEYOND Represent the First Global Phase [...]
Herantis appoints experienced drug development expert Dr Juha Savola as Chief Medical Officer
25/06/2026
Brings more than 25 years of global drug development, regulatory and strategic leadership experience successfully guiding innovative therapies from clinical development through regulatory approval and commercialization [...]
AnaCardio´s Phase 1b/2a GOAL-HF1 study in patients with Heart Failure and Reduced Ejection Fraction (HFrEF) published in The Lancet
25/06/2026
Favourable safety profile in marked contrast to traditional inotropic therapeutics AC01 showed rapid and sustained numerical improvements in cardiac output, structure and function STOCKHOLM, Sweden, June 25, 2026 – [...]
Vivani Medical Receives Regulatory Approval for the Initiation of SLIM-1, a Phase 1 Clinical Trial of NPM-139 Semaglutide Implant in Obesity and Chronic Weight Management
25/06/2026
ALAMEDA, Calif., June 25, 2026 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” or the “Company”), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, [...]

Pages